Increased Interleukin-32 Expression in Chronic Hepatitis B Virus-Infected Liver

Qihuan Xu,Xingfei Pan,Xin Shu,Hong Cao,Xuejun Li,Ka Zhang,Jianxi Lu,Yong Zou,Xueling Li,Hongcan Liu,Yeqiong Zhang,Daofeng Yang,Qin Ning,Guanxin Shen,Gang Li
DOI: https://doi.org/10.1016/j.jinf.2012.05.009
IF: 28.2
2012-01-01
Journal of Infection
Abstract:OBJECTIVES:The role of interleukin-32 (IL-32) in chronic hepatitis B (CHB) remains unclear. In order to identify the role of IL-32 in CHB, we detected the expression levels of IL-32 in liver samples of CHB patients and analyzed the correlation between IL-32 and liver inflammation/fibrosis.METHODS:Real-time PCR and immunohistochemistry were used to detect the expression levels of IL-32 in liver tissues of patients with CHB. The correlation between hepatic IL-32 expression and the severity of liver inflammation/fibrosis was assessed using Spearman's correlation.RESULTS:Hepatic IL-32 expression was increased in CHB patients and increased with the severity of liver inflammation/fibrosis. Moreover, hepatic IL-32 expression was significantly positively correlated with serum ALT level and negatively related with serum ALB level.CONCLUSIONS:Our results suggest that IL-32 could be implicated in HBV-related liver inflammation/fibrosis. We believe that IL-32 might play important roles in the pathogenesis of CHB.
What problem does this paper attempt to address?